We then explored the activity of common therapies used to treat ACC in the clinic14 (mitotane, etoposide, doxorubicin, and carboplatin) among DLK1+ ACC PDOs with and without response to ADCT-701 and PBD. Here, DLK1 is linked to adrenal cortex carcinoma.